North America Metabolic Testing Market

North America Metabolic Testing Market Size & Growth (2023 to 2028)

According to the North America Metabolic Testing Market Forecast Report, the market is valued at USD 143.53 million in 2023 and estimated to grow at a CAGR of 8%, to reach USD 210.90 million by 2028 during the forecast period 2023 to 2028. 

The metabolic testing market in North America is predicted to rise due to rising healthcare spending, the prevalence of lifestyle disorders including diabetes and obesity, greater healthcare literacy, and technological advances.

As the prevalence of lifestyle diseases rises, the demand for metabolic testing should move the North American metabolic testing business forward. Various healthcare and IT projects have been successfully integrated thanks to technological advancements in the healthcare IT business. The healthcare industry uses cloud computing, data mining, big data, and patient monitoring. However, metabolic testing is still not necessary outside of situational requirements, and it has yet to reach its full potential. In this situation, linked and portable metabolic testing devices can significantly improve metabolic testing accessibility.

Over 650 million adults and 41 million children under the age of five were obese, according to the World Health Organization (WHO). Obesity caused roughly 4.7 million people to die prematurely, according to the Global Burden of Disease research. 

As a result, the metabolic testing market is being driven by the rising prevalence of lifestyle disorders such as cardiovascular disease, obesity, and diabetes, as well as technological developments and healthcare spending, which are the factors that drive the market forward during the forecast period.

Some of the primary barriers in the North American metabolic testing industry are the high cost of equipment and software and reimbursement issues.

With the Covid-19 virus spreading across Africa, there is a critical scarcity of life-saving devices and other essential medical supplies required to contain the pandemic and offer the best possible care to sick patients. The Corona Virus Outbreak is notable because it has far-reaching market implications. A range of companies are concerned about supply chain disruptions, the possibility of a recession, and consumer spending declines. In addition, the Comprehensive Metabolic Testing market could lose income because of a preference for COVID-19 patients, who may require critical care therapy using innovative technologies during this pandemic.

This research report on the North America Metabolic Testing Market has been segmented and sub-segmented into the following categories:

By Product:

• CPET
• Body Composition Analysis
• ECG
• Portable System

By Application:

• Critical Care
• Lifestyle Diseases

By Technology:

• REE
• Body Composition Analysis

By End User:

• Gym
• Sports
• Hospital

By Country:

• U.S
• Canada
• Rest of North America

Geographically, the North America Metabolic Testing Market is expected to dominate the global metabolic testing market due to the rise in prevalence of lifestyle disorders such as cardiovascular disease, obesity, and type 2 diabetes in this region drives the expansion of the market in the North America region.

The U.S Metabolic Testing Market would dominate the North American Metabolic Testing market because healthcare spending is rising, and lifestyle problems such as obesity and diabetes are becoming more widespread. In addition, as healthcare awareness improves and better technology becomes available, the metabolic testing sector will likely rise.

Increased industry consolidation and new product releases are two main prospects for the North American metabolic testing market. In addition, during the projection period, the market expansion is expected to be aided by introducing digital rate testing equipment, increased attention to individual health, and rapidly rising healthcare expenditure levels.

The Canada Metabolic Testing Market is likely to hold a significant market in the North American region due to the rise in new technologies, which boosts the regional market expansion and the well-established healthcare institutions and the use of the metabolic testing during the forecast period.

According to the American Diabetes Association, the United States has 34.2 million diabetics or 10.5 percent of the population.

KEY MARKET PLAYERS

Prominent Companies dominating the North America Metabolic Testing Market profiled in this report are Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).,